PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Metsä Board Oyj (METSA.HE)
5.580.04 (-0.71%)
5.38 - 5.60
4.95 - 8.28
2.3K / 2.4K (Avg.)
-279.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.54%
Positive revenue growth while VALMT.HE is negative. John Neff might see a notable competitive edge here.
-5.90%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-8.41%
Negative EBIT growth while VALMT.HE is at 30.36%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-8.41%
Negative operating income growth while VALMT.HE is at 30.36%. Joel Greenblatt would press for urgent turnaround measures.
-10.47%
Negative net income growth while VALMT.HE stands at 34.21%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-8.60%
Negative EPS growth while VALMT.HE is at 30.77%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-8.60%
Negative diluted EPS growth while VALMT.HE is at 30.77%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-2.06%
Share reduction while VALMT.HE is at 2.63%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.06%
Reduced diluted shares while VALMT.HE is at 2.63%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
42.67%
OCF growth under 50% of VALMT.HE's 393.02%. Michael Burry might suspect questionable revenue recognition or rising costs.
99.25%
FCF growth under 50% of VALMT.HE's 272.58%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-29.49%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 34.25%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-4.39%
Negative 5Y CAGR while VALMT.HE stands at 40.85%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
16.34%
3Y revenue/share CAGR at 50-75% of VALMT.HE's 27.56%. Martin Whitman would question if the firm lags behind competitor innovations.
-41.77%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 1494.79%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-14.26%
Negative 5Y OCF/share CAGR while VALMT.HE is at 4.43%. Joel Greenblatt would question the firm’s operational model or cost structure.
-31.60%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 5.30%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
138.09%
Net income/share CAGR 1.25-1.5x VALMT.HE's 111.71%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
56.90%
Below 50% of VALMT.HE's 209.09%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
82.83%
3Y net income/share CAGR 75-90% of VALMT.HE's 100.00%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
52.58%
5Y equity/share CAGR above 1.5x VALMT.HE's 11.69%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.39%
3Y equity/share CAGR above 1.5x VALMT.HE's 9.86%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.70%
Firm’s AR is declining while VALMT.HE shows 5.54%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-3.27%
Inventory is declining while VALMT.HE stands at 2.55%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-0.08%
Negative asset growth while VALMT.HE invests at 5.72%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
3.61%
BV/share growth above 1.5x VALMT.HE's 0.37%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-1.14%
We’re deleveraging while VALMT.HE stands at 6.40%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-12.62%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.